تالیفات

 

Clinical and preclinical manifestation of systemic lupus erythmatous

Authers: M. Ebrahimpur Fini, MD, T. Faezi, MD, M. Akbarian, MD, M. Akhlaghi, MD, M. Kheiyrandish, MD, A. Shahali, MD, F. Gharibdoust, MD, F. Shahram, MD, A.H. Naji, MD, A.R. Jamshidi, MD, F. Davachi, MD

Abstract: Systemic lupus erythmatous (SLE) is a disease of unknown etiology with wide variety of clinical and immunological features. Our objective was to describe the clinical manifestation and laboratory data in Iranian male patients. Methods: 2279 patients were entered in a cross sectional study. The data were collected from rheumatologic research center in Shariati hospital of Tehran University. The prevalence of clinical and immunological features were compared between male and female patients Results: 227 patients (9.7%) were male ... سال انتشار: 2011
 

Effects of intravenous Semelil (ANGIPARSTM) on diabetic foot ulcers healing: A multicenter clinical trial

Authers: Larijani B, Heshmat R, Bahrami A, Delshad H, 5Ranjbar Omrani G, Mohammad K, Heidarpour R, Mohajeri Tehrani MR, Kamali K, Farhadi M, Gharibdoust F, , Madani SH

Abstract: Some diabetic foot ulcers, which are notoriously difficult to cure, are one of the most common health problems in diabetic patients .There are several surgical and medical options which already have been introduced for treatment of diabetic foot ulcers, so some patient will require amputation. The purpose of this study was to evaluate the efficacy of intravenous Semelil (ANGIPARSTM), a naive herbal extract to accelerate healing of diabetic foot ulcers. A multi-centric randomized controlled trial ... سال انتشار: 2008
 

Effect of ANGIPARS™, a new herbal drug on diabetic foot ulcer: A phase 2 clinical study

Authers: Masoompour SM, , 2Bagheri MH, , 3Borhani Haghighi A, , 4Novitsky YA, , Sadeghi B, Gharibdoust F, Larijani B, 1Ranjbar Omrani G

Abstract: Diabetes foot ulcers are a major predictor of future lower-extremity amputation in patients with diabetes. The animal studies have indicated that treatment with a new herbal extract named ANGIPARS™ improves healing of chronic ulcers. The main objective of the study was to evaluate the safety and healing rates of diabetic foot ulcers in patients treated with ANGIPARS™. Ten diabetic patients (7 males and 3 females) were eligible for enrollment in this single arm before-after clinical trial. ... سال انتشار: 2008
 

Clinical application of oral form of ANGIPARS™ and in combination with topical form as a new treatment for diabetic foot ulcers: A randomized clinical trial

Authers: 1Bahrami A, , 2Kamali K, , 1Ali-Asgharzadeh A, , 3Hosseini P, , Heshmat R, , Khorram Khorshid HR, , Gharibdoust F, , 6Madani SH, , 3Larijani B

Abstract: ANGIPARS™ is a new herbal extract which has been produced in oral, topical, and intravenous forms. The present article contains preliminary results of the study which was planned to evaluate the efficacy and safety of orally applied ANGIPARS™ and to compare it with the combination of oral and topical forms and also with conventional therapy in patients with diabetic ulcers of the lower extremities. Twenty one patients with diabetic foot ulcers were divided into 3 ... سال انتشار: 2008
 

Assessment of maximum tolerated dose of a new herbal drug, Semelil (ANGIPARSTM) in patients with diabetic foot ulcer: A Phase I clinical trial

Authers: Heshmat R, , 1Mohammad K, , 2Mohajeri Tehrani MR, 2Tabatabaie Malazy O, Keshtkar AA, Gharibdoust F, , 2Larijani B

Abstract: Background and the purpose of the study: In many cases of diabetic foot ulcer (DFU) management, wound healing is incomplete, and wound closure and epithelial junctional integrity are rarely achieved. Our aim was to evaluate the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) of Semelil (ANGIPARSTM), a new herbal compound for wound treatment in a Phase I clinical trial. Methods: In this open label study, six male diabetic patients with a mean age of ... سال انتشار: 2008
 

The Study Of Osteoporotic Femoral Neck Fractures In The Hospitals Of Tehran In 1380.

Authers: F. Gharibdoust, H. Golshahi, R. Kiani, A. Mohammadi Rad, S. Nafei

Abstract: AIM and BACKGROUND: Osteoporosis is a health growing problem among senile .About 25 millions of people in the USA are suffering from osteoporosis who are dominantly women .The probability of women to men ratio is 5 to 1. There are more than 1.5 millions bone fractures because of osteoporosis that 300000 of them are at hip, 200000 at wrist and 500000 at vertebrae column. Hip fracture has the highest mortality ... سال انتشار: 2001
 

PREGNANCY OUTCOME IN SYSTEMIC LUPUS ERYTHEMATOSUS.

Authers: M. Akbarian, F. Pouryousef, F. Shahram, F. Gharibdoust, A. Nadji, A.R. Jamshidi, F. Davatchi.

Abstract: Objective: To assess the course of maternal disease and outcome of preg­nancy in patients with systemic lupus erythematosus (SLE). Patients and Methods: One hundred SLE patients who carried out 128 pregnancies were studied retrospectively. These patients were followed in lupus unit every one to two months by the rheumatologist and obstetrician team throughout pregnancy. Some patients were given prophylactic low-dose Prednisolone. Lupus flares were treated by increasing Prednisolone doses. Patients who ... سال انتشار: 1999